Hepatic P-Glycoprotein Changes with Total Parenteral Nutrition Administration

Journal of Parenteral and Enteral Nutrition

Volumn 28, Issue 1, 2004, Pages 1-6

  Tazuke, Yuko ^a   Kiristioglu, Irfan ^a   Heidelberger, Kathleen P ^a   Eisenbraun, Michael D ^a   Teitelbaum, Daniel H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; CARRIER PROTEIN; DNA; GLYCOPROTEIN P; GUANOSINE PHOSPHATE; LACTATE DEHYDROGENASE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; GENE; GENE EXPRESSION; IMMUNOBLOTTING; LIVER DISEASE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOTAL PARENTERAL NUTRITION;

ANIMALIA;

EID: 0345825871     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710402800101     Document Type: Article

References (38)

1. Teitelbaum D. Parenteral nutrition-associated cholestasis. Curr Opin Pediatr. 1997;9:270-275.
2. Karrer F, Bensard D. Neonatal cholestasis. Semin Pediatr Surg. 2000;9:166-169.
3. Beath S, Davies P, Papadpoulou A, et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg. 1996;31:604-606.
4. Ginn-Pease M, Pantalos D, King D. TPN-associated hyperbilirubinemia: a common problem in newborn surgical patients. J Pediatr Surg. 1985;20:436-439.
5. Farrell MK, Balistreri WF. Parenteral nutrition and hepatobiliary dysfunction. Clin Perinatol. 1986;13:197-212.
6. Merritt RJ. Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr. 1986;5:9-22.
7. Moss RL, Amii LA. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis. Semin Pediatr Surg. 1999;8:140-147.
8. Trauner M, Meier P, Boyer J. Mechanisms of disease: molecular pathogenesis of cholestasis. New Engl J Med. 1998;339:1217-1227.
9. Trauner M. Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations. Yale J Biol Med. 1998;70:365-378.
10. Muller M, Roelofsen H, Jansen PL. Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistance protein. Semin Liver Dis. 1996;16:211-220.
11. Oude Elferink R, Meijer D, Kuipers F, Jansen PL, Groen AK, Groothuis GM. Hepatobiliary secretion of organic compounds: molecular mechanisms of membrane transport. Biochim Biophys Acta. 1995;1241:215-218.
12. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001;11:1156-1166.
13. Smit JJ, Schinkel AH, Oude Elferink RP, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 1993;75:451-462.
14. Duerksen DR, Van Aerde JE, Chan G, Thomson AB, Jewell LJ, Clandinin MT. Total parenteral nutrition impairs bile flow and alters bile composition in newborn piglet. Dig Dis Sci. 1996;41:1864-1870.
15. Das J, Poulos N, Ansari G. Biliary lipid composition and bile acid profiles during and after enteral fast of total parenteral nutrition in the rabbit. J Pediatr Gastro Nutr. 1996;22:85-91.
16. Kiristioglu I, Teitelbaum DH. Alteration of the intestinal intraepithelial lymphocytes during total parenteral nutrition. J Surg Res. 1998;79:91-96.
17. Li J, Kudsk KA, Gocinski B, Dent D, Glezer J, Langkamp-Henken B. Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue. J Trauma. 1995;39:44-52.
18. Evans W. Fractionation of liver plasma membranes prepared by zonal centrifugation. Biochem J. 1970;166:833-842.
19. Doucet J, Trifaro J. A discontinuous and highly porous sodium dodecyl sulfate polyacrylamide slab gel system of high resolution. Anal Biochem. 1988;168:265-271.
20. Scheffer G, Kool M, Heijn M. Specific detection of multidrug resistance protein MRP1, MRP2, MRP3, MRP5 and MDR2 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res. 2000;60:5269-5277.
21. Hoolveld G, Vos T, Scheffer G. 3-Hydroxy-3methylglutaryl-coensyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats. Gastroenterology. 1999;117:678-687.
22. Lee J, Trauner M, Soroka C. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology. 2000;118:163-172.
23. Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr. 1971;78:180-181.
24. Sax HC, Bower RH. Hepatic complications of total parenteral nutrition. JPEN. 1988;12:615-618.
25. Bell RL, Ferry GD, Smith EO, et al. Total parenteral nutrition-related cholestasis in infants. JPEN. 1986;10:356-359.
26. Gottesman M, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385-427.
27. Crawford A, Smith A, Hatch V. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression: visualization by electron microscopy. J Clin Invest. 1997;100:2562-2567.
28. Dawes L, Greiner M, Joehl R. Altered gallbladder bile acidification with long-term total parenteral nutrition. J Surg Res. 1999;81:21-26.
29. Lown K, Mayo R, Leichtman A, et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine A. Clin Pharm Ther. 1997;62:248-260.
30. Tong AW, Su D, Mues G, et al. Enhancement of doxorubicin cytotoxicity to human hepatocellular carcinoma cells with post-liver transplant patient plasma containing cyclosporine A [abstract]. Proc Annu Meet Am Assoc Cancer Res. 1996;37:A2242.
31. Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotokin and inflammatory cytokines in mice. Int Immunopharmacol. 2001;1:189-199.
32. Tracy TF Jr, Fox ES. CD14-lipopolysaccharide receptor activity in hepatic macrophages after cholestatic liver injury. Surgery. 1995;118:371-377.
33. Trauner M, Arrese M, Lee H, Boyer JL, Karpen SJ. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest. 1998;101:2092-2100.
34. Vos T, Hooiveld G, Koning H, et al. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter mrp2, and bile salt transporter, spgp, in endotoxemic rat liver. Hepatology. 1998;28:1637-1644.
35. Fickert P, Zollner G, Fuchsbichler A. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology. 2001;121:170-183.
36. Chianale J, Vollrath V, Wielandt AM, et al. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem J. 1996;314:781-786.
37. Hyogo H, Tazuma S, Nishioka T. Phospholipid alterations in Hepatocyte membranes and transporter protein changes in cholestatic rat model. Dig Dis Sci. 2001;46:2089-2097.
38. Vos T, Ros JRH. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology. 1999;29:1833-1839.